{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:50:00Z","timestamp":1760622600811},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1989,9,1]],"date-time":"1989-09-01T00:00:00Z","timestamp":620611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1989,9]]},"DOI":"10.1378\/chest.96.3.583","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T18:25:26Z","timestamp":1194459926000},"page":"583-588","source":"Crossref","is-referenced-by-count":13,"title":["Nedocromil Sodium and Placebo in the Treatment of Bronchial Asthma"],"prefix":"10.1016","volume":"96","author":[{"given":"Joel","family":"Greif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gershon","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehoshua","family":"Smorzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Topilsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Bruderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon A.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.96.3.583_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/adc.60.4.376","article-title":"International trends in hospital admission rates for asthma","volume":"60","author":"Mitchell","year":"1985","journal-title":"Arch Dis Childhood"},{"key":"10.1378\/chest.96.3.583_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(86)90012-7","article-title":"Asthma mortality in England and Wales: evidence for a further increase","volume":"2","author":"Burney","year":"1986","journal-title":"Lancet"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib3","first-page":"175","article-title":"Why are deaths from asthma increasing?","volume":"69","author":"Sears","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/bmj.289.6441.348","article-title":"Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom 1975\u201381","volume":"289","author":"Keating","year":"1984","journal-title":"Br Med J"},{"key":"10.1378\/chest.96.3.583_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/thx.41.9.657","article-title":"Role of inflammation in the hyperreactivity of the airways in asthma","volume":"41","author":"Chung","year":"1986","journal-title":"Thorax"},{"key":"10.1378\/chest.96.3.583_bib6","first-page":"359","article-title":"The changing face of asthma","volume":"63","author":"Barnes","year":"1987","journal-title":"QJ Med"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib7","first-page":"238","article-title":"The differential effects of nedocromil sodium and sodium cromoglycate on the secretory response of rabbit peritoneal neutrophils","volume":"69","author":"Bradford","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1398-9995.1988.tb00899.x","article-title":"Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells","volume":"43","author":"Moqbel","year":"1988","journal-title":"Allergy"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib9","first-page":"241","article-title":"The effect of nedocromil sodium on secretion from human eosinophils","volume":"69","author":"Spry","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000234507","article-title":"Regulation of IgE-dependent antiparasite functions of rat macrophages and platelets by nedocromil sodium","volume":"85","author":"Thorel","year":"1988","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1378\/chest.96.3.583_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000234508","article-title":"Inhibition by nedocromil sodium of IgE-mediated activation of human mononuclear phagocytes and platelets in allergy","volume":"85","author":"Thorel","year":"1988","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1378\/chest.96.3.583_bib12","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.4049\/jimmunol.137.12.3941","article-title":"Characterization of primate bronchoalveolar mast cells: II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells","volume":"137","author":"Wells","year":"1986","journal-title":"J Immunol"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib13","first-page":"223","article-title":"A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments","volume":"69","author":"Leung","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib14","first-page":"398","article-title":"Preventative effect of nedocromil sodium on the abnormal response to aspirin of platelets from aspirin-sensitive asthmatics","volume":"135","author":"Thorel","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0007-0971(85)90073-7","article-title":"Nedocromil, a mucosal and connective tissue mast cell stabilizer, inhibits exercise-induced asthma","volume":"79","author":"Shaw","year":"1985","journal-title":"Br J Dis Chest"},{"key":"10.1378\/chest.96.3.583_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1398-9995.1988.tb00917.x","article-title":"Effect of nedocromil sodium on exercise-induced bronchoconstriction in children","volume":"43","author":"Henriksen","year":"1988","journal-title":"Allergy"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib17","first-page":"274","article-title":"Inhibition of sulphur dioxide-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in non-asthmatic, atopic subjects","volume":"69","author":"Altounyan","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/thx.42.6.462","article-title":"Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction","volume":"42","author":"Dixon","year":"1987","journal-title":"Thorax"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib19","first-page":"277","article-title":"A comparison of the inhibitory effects of nedocromil sodium and sodium cromoglycate on adenosine monophosphate-induced bronchoconstriction in atopic subjects","volume":"69","author":"Altounyan","year":"1986","journal-title":"Eur J Respir Dis"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib20","first-page":"263","article-title":"Influence of nedocromil sodium on the dual asthmatic reaction after allergen challenge: a double-blind, placebo-controlled study","volume":"69","author":"Dahl","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib21","first-page":"393","article-title":"Effect of nedocromil sodium on the dual reaction to bronchial antigen challenge in asthmatic patients","volume":"135","author":"Brusasco","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"suppl 8","key":"10.1378\/chest.96.3.583_bib22","first-page":"720","article-title":"A double-blind crossover trial with nedocromil sodium on the dual asthmatic reaction after antigen challenge","volume":"22","author":"Joubert","year":"1986","journal-title":"Bull Eur Physiopath Respir"},{"key":"10.1378\/chest.96.3.583_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000234265","article-title":"Primary and secondary effector cells in the pathogenesis of bronchial asthma","volume":"82","author":"Holgate","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1378\/chest.96.3.583_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0091-6749(82)90038-0","article-title":"Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway calibre","volume":"70","author":"Carrier","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.96.3.583_bib25","series-title":"A Friedman-type rank test for main effects in a two-factor ANOVA","first-page":"75","author":"Mack","year":"1980"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib26","first-page":"143","article-title":"A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report","volume":"69","author":"Van As","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib27","unstructured":"Canadian Multicentre Study Group. Nedocromil sodium in the management of reversible obstructive airways disease. Eur Respir J 1988; 1(suppl 2):197"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib28","first-page":"336","article-title":"A 4-week Australian multicentre study of nedocromil sodium in asthmatic patients","volume":"69","author":"Ruffin","year":"1986","journal-title":"Eur J Respir Dis"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib29","first-page":"330","article-title":"Withdrawal of inhaled cortocosteroid under cover of nedocromil sodium","volume":"69","author":"Paananen","year":"1986","journal-title":"Eur J Respir Dis"},{"issue":"suppl","key":"10.1378\/chest.96.3.583_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1164\/ajrccm\/136.4_Pt_2.S35","article-title":"Airway inflammation and bronchial hyperresponsiveness","volume":"136","author":"O'Byrne","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib31","first-page":"477","article-title":"Basic mechanisms in asthma","volume":"60","author":"Wasserman","year":"1988","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.96.3.583_bib32","series-title":"Drug therapy for asthma: research and clinical practice","first-page":"719","article-title":"Corticosteroids","author":"Toogood","year":"1987"},{"key":"10.1378\/chest.96.3.583_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1542\/peds.72.1.60","article-title":"Effect of inhaled beclomethasone dipropionate on hypothalamic-pituitary-adrenal axis function in children with asthma","volume":"72","author":"Goldstein","year":"1983","journal-title":"Pediatrics"},{"key":"10.1378\/chest.96.3.583_bib34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1378\/chest.71.6.698","article-title":"The endocrinometabolic effects of beclomethasone dipropionate in asthmatic patients","volume":"71","author":"Yernault","year":"1977","journal-title":"Chest"},{"key":"10.1378\/chest.96.3.583_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0091-6749(77)90051-3","article-title":"A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma","volume":"59","author":"Toogood","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.96.3.583_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0091-6749(82)90065-3","article-title":"Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide","volume":"70","author":"Toogood","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.96.3.583_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-6749(88)91015-9","article-title":"Inhaled corticosteroids\u2014their present and future role in the management of asthma","volume":"82","author":"K\u00f6nig","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.96.3.583_bib38","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/030006058801600509","article-title":"The acceptability, safety and efficacy of nedocromil sodium in long-term clinical use in patients with perennial asthma","volume":"16","author":"Carrasco","year":"1988","journal-title":"J internat Med Res"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib39","first-page":"136","article-title":"An open assessment of the acceptability, tolerability and safety of nedocromil sodium in long-term clinical use in patients with bronchial asthma","volume":"69","author":"Lal","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.1378\/chest.96.3.583_bib40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2165\/00003495-198734050-00004","article-title":"Nedocromil sodium: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease","volume":"34","author":"Gonzalez","year":"1987","journal-title":"Drugs"},{"key":"10.1378\/chest.96.3.583_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2125.1987.tb03203.x","article-title":"The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease","volume":"24","author":"Neale","year":"1987","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib42","first-page":"314","article-title":"A trial comparing nedocromil sodium (Tilade) and placebo in the management of perennial bronchial asthma","volume":"69","author":"Chatterjee","year":"1986","journal-title":"Eur J Respir Dis"},{"issue":"suppl 2","key":"10.1378\/chest.96.3.583_bib43","first-page":"203","article-title":"The use of nedocromil sodium (Tilade) in steroid-dependent asthma","volume":"1","author":"Bone","year":"1988","journal-title":"Eur Respir J"},{"issue":"suppl 147","key":"10.1378\/chest.96.3.583_bib44","first-page":"340","article-title":"The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma","volume":"69","author":"Williams","year":"1986","journal-title":"Eur J Respir Dis"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215460714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215460714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T17:11:20Z","timestamp":1684084280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215460714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,9]]}},"alternative-id":["S0012369215460714"],"URL":"https:\/\/doi.org\/10.1378\/chest.96.3.583","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1989,9]]}}}